Accepted for/Published in: JMIR Research Protocols
Date Submitted: Aug 12, 2021
Date Accepted: Dec 8, 2021
Novel Data Collection and Analytics Tools for Remote Patient Monitoring in Heart Failure (Nov-RPM-HF) Trial: Protocol for Trial Design
ABSTRACT
Heart Failure (HF) remains a leading cause of mortality, and a major driver of healthcare utilization. Effective outpatient management requires the ability to identify and manage impending HF decompensation. Remote patient monitoring (RPM) aims to further address this current need in HF care. To date, RPM approaches employing noninvasive, home-based patient sensors have failed to demonstrate clinical efficacy. The Novel Data Collection and Analytics Tools for Remote Patient Monitoring in Heart Failure Trial (Nov-RPM-HF) aims to address current noninvasive RPM limitations. Nov-RPM-HF will evaluate a clinician-codesigned RPM platform employing emerging data collection and presentation tools. These tools include: (1) a ballistocardiograph to monitor nocturnal patient biometrics, such as heart and respiratory rate, (2) clinical alerts for abnormal biometrics, and (3) longitudinal data presentation for clinician review. Nov-RPM-HF is a 100-patient single-center prospective trial, evaluating patients over 6 months. Outcomes will include: (1) patient adherence to data collection, (2) patient/clinician-perceived utility of the RPM platform, (3) medication changes- including the titration of guideline-directed medical therapy to target doses, (4) HF symptoms/performance status, and (5) unplanned HF hospitalizations or emergency department visits. The results will help to inform the role of noninvasive RPM as a viable clinical management strategy in HF care.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.